New pyridinyl-amino:methylidene bis:phosphonic acid derivs. - used to treat bone disease e.g. osteolytic bone diseases due to malignancy, Paget's disease and osteoporosis

Pyridinyl-aminomethylidene bisphosphonic acid tetraesters of formula (I) are new: R1-R4 = 1-5C alkyl; X, Y = H, 1-5C alkyl, halo, OH, 1-5C alkoxy, benzyloxy, acyloxy, NO2, CF3 or NR5R6; R5, R6 = H, 1-5C alkyl or acyl. Also claimed is the use of (I) for the treatment of bone diseases, and a pharmaceu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIUKKO-SIPI,SIRPA, NIKANDER,HANNU, KLEIMOLA,TERTTU, SELLMAN,RAIJA, VAEAENAENEN,KALERVO, HEIKKILAE-HOIKKA,MARJAANA, HANNUNIEMI,RITVA, LAUREN,LEENA
Format: Patent
Sprache:eng ; fin ; swe
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIUKKO-SIPI,SIRPA
NIKANDER,HANNU
KLEIMOLA,TERTTU
SELLMAN,RAIJA
VAEAENAENEN,KALERVO
HEIKKILAE-HOIKKA,MARJAANA
HANNUNIEMI,RITVA
LAUREN,LEENA
description Pyridinyl-aminomethylidene bisphosphonic acid tetraesters of formula (I) are new: R1-R4 = 1-5C alkyl; X, Y = H, 1-5C alkyl, halo, OH, 1-5C alkoxy, benzyloxy, acyloxy, NO2, CF3 or NR5R6; R5, R6 = H, 1-5C alkyl or acyl. Also claimed is the use of (I) for the treatment of bone diseases, and a pharmaceutical compsn. contg. (I). In an example, 0.2 moles 2-aminopyridine were mixed with 0.8 mol triethylorthoformate and BF3.OEt2 and the mixt.heated at 150[deg]C for 4 hr. and the EtOH formed was distilled off. Triethylorthoformate was distilled off in vacuum. 0.4 mol diethylphosphite was then added to the reaction mixt. which was heated at 150[deg]C while distilling off the EtOH formed. The mixt. was cooled and the prod. purified to give 29g ((2-pyridinylamino) methylidene)bisphosphonic acid tetraethyl ester.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_FI117053BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FI117053BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_FI117053BB3</originalsourceid><addsrcrecordid>eNqFjrEKwkAQRNNYiPoNbmdjgiIiWCqKNmJhH9bcGhcut0f2otwv-ZVGFLGzGKaYecN0k8eB7uBjzYZdtClW7GRZUbhGy4YcwZl16a-irRwXgAUbMFTzTTNIoVEyEARCTRjgLC1gWAmVgLIyA9FAYmNoyd9QwTT04iq0XDp0RRzDEUsKI_0OoDNv3kstytpPOhe0SoOP95LhdnNa71LykpN6LNq_Id_up9PFZD5brWb_G09EoFel</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>New pyridinyl-amino:methylidene bis:phosphonic acid derivs. - used to treat bone disease e.g. osteolytic bone diseases due to malignancy, Paget's disease and osteoporosis</title><source>esp@cenet</source><creator>LIUKKO-SIPI,SIRPA ; NIKANDER,HANNU ; KLEIMOLA,TERTTU ; SELLMAN,RAIJA ; VAEAENAENEN,KALERVO ; HEIKKILAE-HOIKKA,MARJAANA ; HANNUNIEMI,RITVA ; LAUREN,LEENA</creator><creatorcontrib>LIUKKO-SIPI,SIRPA ; NIKANDER,HANNU ; KLEIMOLA,TERTTU ; SELLMAN,RAIJA ; VAEAENAENEN,KALERVO ; HEIKKILAE-HOIKKA,MARJAANA ; HANNUNIEMI,RITVA ; LAUREN,LEENA</creatorcontrib><description>Pyridinyl-aminomethylidene bisphosphonic acid tetraesters of formula (I) are new: R1-R4 = 1-5C alkyl; X, Y = H, 1-5C alkyl, halo, OH, 1-5C alkoxy, benzyloxy, acyloxy, NO2, CF3 or NR5R6; R5, R6 = H, 1-5C alkyl or acyl. Also claimed is the use of (I) for the treatment of bone diseases, and a pharmaceutical compsn. contg. (I). In an example, 0.2 moles 2-aminopyridine were mixed with 0.8 mol triethylorthoformate and BF3.OEt2 and the mixt.heated at 150[deg]C for 4 hr. and the EtOH formed was distilled off. Triethylorthoformate was distilled off in vacuum. 0.4 mol diethylphosphite was then added to the reaction mixt. which was heated at 150[deg]C while distilling off the EtOH formed. The mixt. was cooled and the prod. purified to give 29g ((2-pyridinylamino) methylidene)bisphosphonic acid tetraethyl ester.</description><language>eng ; fin ; swe</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060531&amp;DB=EPODOC&amp;CC=FI&amp;NR=117053B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20060531&amp;DB=EPODOC&amp;CC=FI&amp;NR=117053B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIUKKO-SIPI,SIRPA</creatorcontrib><creatorcontrib>NIKANDER,HANNU</creatorcontrib><creatorcontrib>KLEIMOLA,TERTTU</creatorcontrib><creatorcontrib>SELLMAN,RAIJA</creatorcontrib><creatorcontrib>VAEAENAENEN,KALERVO</creatorcontrib><creatorcontrib>HEIKKILAE-HOIKKA,MARJAANA</creatorcontrib><creatorcontrib>HANNUNIEMI,RITVA</creatorcontrib><creatorcontrib>LAUREN,LEENA</creatorcontrib><title>New pyridinyl-amino:methylidene bis:phosphonic acid derivs. - used to treat bone disease e.g. osteolytic bone diseases due to malignancy, Paget's disease and osteoporosis</title><description>Pyridinyl-aminomethylidene bisphosphonic acid tetraesters of formula (I) are new: R1-R4 = 1-5C alkyl; X, Y = H, 1-5C alkyl, halo, OH, 1-5C alkoxy, benzyloxy, acyloxy, NO2, CF3 or NR5R6; R5, R6 = H, 1-5C alkyl or acyl. Also claimed is the use of (I) for the treatment of bone diseases, and a pharmaceutical compsn. contg. (I). In an example, 0.2 moles 2-aminopyridine were mixed with 0.8 mol triethylorthoformate and BF3.OEt2 and the mixt.heated at 150[deg]C for 4 hr. and the EtOH formed was distilled off. Triethylorthoformate was distilled off in vacuum. 0.4 mol diethylphosphite was then added to the reaction mixt. which was heated at 150[deg]C while distilling off the EtOH formed. The mixt. was cooled and the prod. purified to give 29g ((2-pyridinylamino) methylidene)bisphosphonic acid tetraethyl ester.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjrEKwkAQRNNYiPoNbmdjgiIiWCqKNmJhH9bcGhcut0f2otwv-ZVGFLGzGKaYecN0k8eB7uBjzYZdtClW7GRZUbhGy4YcwZl16a-irRwXgAUbMFTzTTNIoVEyEARCTRjgLC1gWAmVgLIyA9FAYmNoyd9QwTT04iq0XDp0RRzDEUsKI_0OoDNv3kstytpPOhe0SoOP95LhdnNa71LykpN6LNq_Id_up9PFZD5brWb_G09EoFel</recordid><startdate>20060531</startdate><enddate>20060531</enddate><creator>LIUKKO-SIPI,SIRPA</creator><creator>NIKANDER,HANNU</creator><creator>KLEIMOLA,TERTTU</creator><creator>SELLMAN,RAIJA</creator><creator>VAEAENAENEN,KALERVO</creator><creator>HEIKKILAE-HOIKKA,MARJAANA</creator><creator>HANNUNIEMI,RITVA</creator><creator>LAUREN,LEENA</creator><scope>EVB</scope></search><sort><creationdate>20060531</creationdate><title>New pyridinyl-amino:methylidene bis:phosphonic acid derivs. - used to treat bone disease e.g. osteolytic bone diseases due to malignancy, Paget's disease and osteoporosis</title><author>LIUKKO-SIPI,SIRPA ; NIKANDER,HANNU ; KLEIMOLA,TERTTU ; SELLMAN,RAIJA ; VAEAENAENEN,KALERVO ; HEIKKILAE-HOIKKA,MARJAANA ; HANNUNIEMI,RITVA ; LAUREN,LEENA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_FI117053BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fin ; swe</language><creationdate>2006</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LIUKKO-SIPI,SIRPA</creatorcontrib><creatorcontrib>NIKANDER,HANNU</creatorcontrib><creatorcontrib>KLEIMOLA,TERTTU</creatorcontrib><creatorcontrib>SELLMAN,RAIJA</creatorcontrib><creatorcontrib>VAEAENAENEN,KALERVO</creatorcontrib><creatorcontrib>HEIKKILAE-HOIKKA,MARJAANA</creatorcontrib><creatorcontrib>HANNUNIEMI,RITVA</creatorcontrib><creatorcontrib>LAUREN,LEENA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIUKKO-SIPI,SIRPA</au><au>NIKANDER,HANNU</au><au>KLEIMOLA,TERTTU</au><au>SELLMAN,RAIJA</au><au>VAEAENAENEN,KALERVO</au><au>HEIKKILAE-HOIKKA,MARJAANA</au><au>HANNUNIEMI,RITVA</au><au>LAUREN,LEENA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>New pyridinyl-amino:methylidene bis:phosphonic acid derivs. - used to treat bone disease e.g. osteolytic bone diseases due to malignancy, Paget's disease and osteoporosis</title><date>2006-05-31</date><risdate>2006</risdate><abstract>Pyridinyl-aminomethylidene bisphosphonic acid tetraesters of formula (I) are new: R1-R4 = 1-5C alkyl; X, Y = H, 1-5C alkyl, halo, OH, 1-5C alkoxy, benzyloxy, acyloxy, NO2, CF3 or NR5R6; R5, R6 = H, 1-5C alkyl or acyl. Also claimed is the use of (I) for the treatment of bone diseases, and a pharmaceutical compsn. contg. (I). In an example, 0.2 moles 2-aminopyridine were mixed with 0.8 mol triethylorthoformate and BF3.OEt2 and the mixt.heated at 150[deg]C for 4 hr. and the EtOH formed was distilled off. Triethylorthoformate was distilled off in vacuum. 0.4 mol diethylphosphite was then added to the reaction mixt. which was heated at 150[deg]C while distilling off the EtOH formed. The mixt. was cooled and the prod. purified to give 29g ((2-pyridinylamino) methylidene)bisphosphonic acid tetraethyl ester.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fin ; swe
recordid cdi_epo_espacenet_FI117053BB
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title New pyridinyl-amino:methylidene bis:phosphonic acid derivs. - used to treat bone disease e.g. osteolytic bone diseases due to malignancy, Paget's disease and osteoporosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T21%3A49%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIUKKO-SIPI,SIRPA&rft.date=2006-05-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EFI117053BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true